{
    "medicine_id": "8b598ed94d2f3791dbcbb2aec88f6c11688423f8",
    "platform_id": "DB05480",
    "metadata": {
        "name": "Adult Formula 50 60 61 v v Solution",
        "composition": "60 61 v v PBI 1402",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in adverse effects chemotherapy anemia and chemotherapy",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "PBI 1402 is a small molecule synthetic compound with oral Bioavailability The compound activates neutrophils enhancing their survival and activation with comparable efficacy to GM CSF G CSF and EPO which are currently used to treat anemia PBI 1402 has a dual therapeutic action as a chemoprotectant and hematopoietic progenitor stimulator",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}